Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Childhood vitiligo.

Nanette B Silverberg1, Lisa Travis

  • 1Pediatric Dermatology Department, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Ave, Suite 11D, New York, NY 10025, USA. nsilverberg@juno.com

Cutis
|July 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes.

Journal of the American Academy of Dermatology·2025
Same author

SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare.

Journal of drugs in dermatology : JDD·2025
Same author

SAIGE II: The Role of Staphylococcus aureus in Skin Barrier Dysfunction and the Development and Severity of Atopic Dermatitis in Young Children.

Journal of drugs in dermatology : JDD·2025
Same author

Photoprotection in Skin of Color: A Scoping Review of Barriers, Behaviors, and Pediatric Considerations.

Pediatric dermatology·2025
Same author

Systematic Review of the Epidemiology and Risk Factors for Nonsexual Transmission of Warts and Molluscum in Children.

Pediatric dermatology·2025
Same author

Autologous cell harvesting device provides repigmentation and improves quality-of-life for patients with stable vitiligo lesions in a large and diverse patient population.

Journal of the American Academy of Dermatology·2025
Same journal

Black Dots on the Scalp of a Child.

Cutis·2026
Same journal

Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

Cutis·2026
Same journal

Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

Cutis·2026
Same journal

The Future of Psoriasis Care.

Cutis·2026
Same journal

Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

Cutis·2026
Same journal

Metastatic Primary Extramammary Paget Disease: A Case Series.

Cutis·2026
See all related articles

Vitiligo, a common skin disorder causing pigment loss, now has effective therapies. Recent studies show 50-75% repigmentation is achievable for recent vitiligo cases.

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Vitiligo is a prevalent skin condition characterized by depigmentation.
  • Onset frequently occurs before age 20, impacting younger individuals significantly.
  • Historically, effective treatment options for vitiligo were limited, with scarce published data.

Purpose of the Study:

  • To review and highlight recent advancements in vitiligo treatment.
  • To inform about the efficacy of current therapeutic strategies for vitiligo.
  • To provide realistic expectations for repigmentation in vitiligo patients.

Main Methods:

  • Literature review of recent studies on vitiligo therapy.
  • Analysis of treatment outcomes and reported repigmentation rates.

Related Experiment Videos

  • Synthesis of current clinical guidelines and therapeutic approaches.

    • Main Results:

    • Current vitiligo therapies are demonstrating significant effectiveness.
    • While complete repigmentation is not always achieved, substantial pigment restoration is possible.
    • 50% to 75% repigmentation is routinely expected for vitiligo cases with recent onset.

    Conclusions:

    • Effective therapeutic options for vitiligo are now available.
    • Patients with recent-onset vitiligo can anticipate significant repigmentation with current treatments.
    • Further research continues to refine vitiligo management strategies.